Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis.

Zhenzhen LiangLianchang LiuChaowei WenHeya JiangTianxia YeShumei MaXiao Dong Liu

Published in: Cancer control : journal of the Moffitt Cancer Center (2022)

For the first time we found PRMT5 was pan-cancerous as a prognostic biomarker and high level of PRMT5 was associated with poor prognosis for certain cancers.

Keyphrases

poor prognosis
long non coding rna
young adults